Third Party Activities Sample Clauses
The Third Party Activities clause defines the rules and responsibilities regarding the involvement of external parties in relation to the agreement. It typically outlines whether and how a party may engage subcontractors, agents, or other third parties to perform obligations or access confidential information under the contract. For example, it may require prior written consent before sharing sensitive data with a third party or impose liability on the contracting party for the actions of their subcontractors. This clause ensures that the original parties maintain control and accountability over the performance and confidentiality of the agreement, even when third parties are involved.
POPULAR SAMPLE Copied 2 times
Third Party Activities. Nothing in this Agreement shall be construed to provide any rights or benefits whatsoever to any party other than CITY and ENGINEER.
Third Party Activities. If you authorize, assist, encourage or facilitate another person or entity to take any action related to the subject matter of this Agreement, you shall be deemed to have taken the action yourself.
Third Party Activities. To FibroGen’s knowledge, except as disclosed in a writing of even date herewith by FibroGen to AstraZeneca, there are no activities by Third Parties that would constitute infringement or misappropriation of the FibroGen Technology (in the case of pending claims, evaluating them as if issued).
Third Party Activities. As of the Effective Date, to Ambit’s Knowledge, there is no actual infringement or overtly threatened infringement of the Ambit Licensed Patents by any Third Party (in the case of pending claims, evaluating them as if issued) or misappropriation of the Ambit Know-How.
Third Party Activities. IM, in a development program with a Third Party outside of the CDP Field, may determine that a specific Product, or an Agreement Compound within a TFS, created pursuant to this CDP may have efficacy for an application outside the CDP Field (“Third Party Opportunity”). IM will promptly notify ATMI and the Operating Committee of any such Third Party Opportunity and, if ATMI so chooses, IM will use all reasonable efforts to engage ATMI as the materials vendor for that program. IM agrees that it will not use the said Product or Agreement Compound outside the CDP Field with a materials vendor who is a direct competitor of ATMI, or otherwise, without agreeing to pay ATMI reasonable compensation for IM’s use of the Product and or Agreement Compound outside the CDP Field. The Operating Committee shall meet promptly after notification by IM to determine, for the specific IM development program with a Third Party, reasonable compensation by IM to ATMI. Disagreement of the Operating Committee regarding such compensation may be submitted for escalation to the chief executive officers of the parties pursuant to the Agreement. If such escalation does not result in a mutually agreed compensation plan, then the revenue share or royalty amounts may be decided by an arbitrator as expressly set forth in this CDP.
Third Party Activities. To FibroGen China’s knowledge, except as disclosed in a writing of even date herewith by FibroGen China to AstraZeneca, there are no activities by Third Parties that would constitute infringement or misappropriation of the FibroGen China Technology (in the case of pending claims, evaluating them as if issued).
Third Party Activities. If the Customer authorizes, assists, encourages or facilitates another person or entity to take any action related to the subject matter of this Agreement, the Customer shall be deemed to have taken the action.
Third Party Activities. Have you performed CMO activities for third parties using the PER.C6® cell line or worked with the PER.C6® cell line in collaborations programs with third parties? If yes, please state the name of the company/companies and a short description of the project(s). • Has a CMO performed any activities with the PER.C6® cell line? If yes, please state the name of the company/companies and a short description of the project(s). Commercial License Agreement PER.C6® Crucell Holland – Vascular Biogenics
Third Party Activities. To Unum’s knowledge, there are no activities by Third Parties that would constitute infringement or misappropriation of the Unum Background Technology (in the case of pending claims, evaluating them as if issued).
Third Party Activities. For the avoidance of doubt, CABG acknowledges that SURMODICS cannot prevent third parties (including other SURMODICS Drug-Delivery Coatings licensees), from incorporating Compounds of interest to CABG into Drug-Delivery Coatings. If any third party (including other SURMODICS Drug-Delivery Coatings licensees), incorporates Compounds of interest to CABG into Drug-Delivery Coatings, nothing in this Agreement shall be construed as (A) requiring SURMODICS to attempt to prevent such third parties from doing so, or (B) relieving CABG of its obligations to SURMODICS (including without limitation the obligation to pay royalties according to the terms of this Agreement). In addition, if any third party incorporates Compounds of interest to CABG into Drug-Delivery Coatings, CABG shall not bring any action against SURMODICS for having supplied, or continuing to supply Reagents to such third party.